Kyverna Therapeutics, Inc. - KYTX

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$319.5M

QoQ value delta ($000)

-$179.5M (-35.96%)

Implied price effect (QoQ)

-40.35%

Total shares

36,867,649

QoQ shares delta

+2,525,947 (+7.36%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 113 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
GordonMD Global Investments LP	36,632	4,244,818	25.51%
GILEAD SCIENCES, INC.	35,608	4,126,119	1.68%
Bain Capital Life Sciences Investors, LLC	26,839	3,110,000	2.42%
DEERFIELD MANAGEMENT COMPANY, L.P.	17,260	2,000,000	0.2%
AIGH Capital Management LLC	17,260	2,000,000	2.35%
VANGUARD GROUP INC	16,743	1,781,257	0.0%
VANGUARD CAPITAL MANAGEMENT LLC	15,390	1,783,342	0.0%
PRICE T ROWE ASSOCIATES INC /MD/	13,423	1,555,287	0.0%
BALYASNY ASSET MANAGEMENT L.P.	9,711	1,125,321	0.01%
MILLENNIUM MANAGEMENT LLC	8,677	1,005,508	0.0%
Insight Holdings Group, LLC	8,535	989,054	0.6%
MORGAN STANLEY	8,434	977,289	0.0%
BlackRock, Inc.	7,569	877,078	0.0%
Woodline Partners LP	7,295	845,325	0.03%
D. E. Shaw & Co., Inc.	6,227	721,581	0.0%
Propel Bio Management, LLC	5,585	644,421	3.52%
SUSQUEHANNA INTERNATIONAL GROUP, LLP	5,466	633,400	0.0%
MBB PUBLIC MARKETS I LLC	5,302	614,477	0.63%
MARSHALL WACE, LLP	5,225	605,512	0.01%
ADAGE CAPITAL PARTNERS GP, L.L.C.	4,315	500,000	0.01%
UBS Group AG	3,881	449,750	0.0%
GEODE CAPITAL MANAGEMENT, LLC	3,659	423,826	0.0%
BNP PARIBAS FINANCIAL MARKETS	3,555	412,032	0.0%
RENAISSANCE TECHNOLOGIES LLC	3,171	367,492	0.0%
Qube Research & Technologies Ltd	2,879	333,692	0.0%